Quick View
| Metric | Current Period | Previous Year Same Period | YoY |
|---|---|---|---|
| Revenue | ¥2680.3B | ¥2426.2B | +10.5% |
| Operating Income | ¥152.3B | ¥-335.5B | +145.4% |
| Profit Before Tax | ¥137.2B | ¥-341.1B | +140.2% |
| Net Income | ¥91.6B | ¥-244.9B | +137.4% |
| ROE | 1.0% | -2.7% | - |
Executive Summary
In Q1, the Company returned to profitability from the significant loss recorded in the same period of the previous year, confirming a recovery in earnings as a financial conglomerate. Revenue (including insurance revenue) was ¥2,680.3B (+10.5% YoY), Operating Income was ¥152.3B (compared with ¥-335.5B in the previous year), Profit Before Tax was ¥137.2B (compared with ¥-341.1B in the previous year), and Net Income was ¥91.6B (compared with ¥-244.9B in the previous year). The primary factors were a significant improvement in life insurance earnings, an increase in interest income against the backdrop of rising interest rates, and a reversal in investment gains and losses. The Company has voluntarily transitioned from Japanese GAAP to IFRS beginning with these financial results; accordingly, this report uses “Profit Before Tax” rather than “Ordinary Income.”
Factors Affecting Earnings
【Revenue】Revenue from external customers was ¥2,680.3B, representing a +10.5% YoY increase. By segment, Life Insurance generated ¥1,814.97B (67.7% of total, +6.8% YoY), Non-Life Insurance generated ¥491.45B (18.3%, +15.1%), and Banking generated ¥329.65B (12.3%, +28.2%). All segments posted revenue growth, with Banking showing particularly strong growth. Interest income, which expanded to ¥786.1B from ¥694.8B in the previous year amid a rising interest-rate environment, was the main growth driver.
【Earnings】 Operating Income was ¥152.3B, representing a return to profitability from ¥-335.5B in the previous year, while Net Income also turned positive at ¥91.6B (compared with ¥-244.9B in the previous year). In the same period of the previous year, deterioration in investment gains and losses (¥-320.2B) was the primary source of losses; in the current period, the sharp reversal in investment gains and losses to ¥671.8B was the largest improvement factor. Meanwhile, insurance finance income and expenses deteriorated to ¥-7,418.9B from ¥-761.8B in the previous year. Within this offsetting structure, financial income and expenses ultimately improved to ¥-107.7B from ¥-598.9B in the previous year. The Company achieved both revenue and earnings growth.
Segment Analysis
Segment profit was ¥689.8B for Non-Life Insurance (¥485.9B in the previous year, 14.0% margin), ¥600.2B for Banking (¥276.5B in the previous year, 18.2% margin), and ¥164.2B for Life Insurance (¥-4,119.2B in the previous year, 0.9% margin). The largest change was the return to profitability of Life Insurance, which had been the primary source of the previous year’s losses. Non-Life Insurance and Banking maintained high profitability while achieving profit and revenue growth from the previous year. In contrast, Life Insurance’s profit margin remains significantly below those of the other segments, indicating a structural difference in earnings contribution. The extent to which Life Insurance can establish sustainable profitability is expected to determine the quality of full-year earnings.
Key Financial Indicators
【Profitability】 Operating margin improved substantially to 5.7% from -13.8% in the previous year, while Net Income margin improved to 3.4% from -10.1%. 【Cash Flow Quality】 Comprehensive income of ¥-59.6B diverged from quarterly Net Income of ¥91.6B, with other comprehensive income (¥-151.2B) indicating headwinds from fair value measurements. 【Investment Efficiency】 ROE remained low at 1.0%, and profit contribution relative to total assets of ¥21.79T remains limited. 【Financial Soundness】 The Equity Ratio declined to 4.0% from 4.4% in the previous year. While this is within the range of characteristics for a combined insurance and banking business, the capital buffer remains limited.
Cash Flow Analysis
Although these financial results do not include explicit data from the cash flow statement, fund movements can be inferred from changes in the balance sheet. Cash and cash equivalents increased by +¥1,614.9B to ¥6,449.6B from ¥4,834.6B at the end of the previous fiscal period. Securities increased to ¥15.92T (+¥7,395.5B), while call money and sale and repurchase agreement accounts, which represent short-term market-based funding, also expanded. This suggests that the Company expanded its scale through a combination of increased investment assets and market-based funding. No share repurchases were conducted, with the amount of share buybacks at ¥0.0B; capital was instead allocated toward increasing assets held and paying dividends.
Quality of Earnings
The core sources of recurring earnings were insurance service income and expenses (¥477.7B) and net interest income (¥589.4B). However, the return to profitability in the current period also depended substantially on a sharp reversal in investment gains and losses (¥671.8B, compared with ¥-320.2B in the previous year). Interest income of ¥786.1B was equivalent to approximately 29% of Revenue, indicating an earnings structure highly sensitive to the interest-rate environment. Meanwhile, insurance finance income and expenses deteriorated to ¥-7,418.9B from the previous year, representing an accounting offsetting relationship that is inseparable from the improvement in investment gains and losses. Comprehensive income was negative at ¥-59.6B compared with Net Income of ¥91.6B. Changes in OCI, primarily related to valuation differences on other securities, are of a scale that cannot be ignored in terms of their impact on shareholders’ equity. Attention should therefore be paid to the fact that improvement in P&L earnings has not directly translated into a stable increase in capital.
Earnings Forecast and Guidance
Progress against the full-year forecast was approximately 25.1% for Revenue at ¥2,680.3B/¥10,700B, in line with the standard quarterly progress rate of 25%. Operating Income reached approximately 52.5% at ¥152.3B/¥290.0B, while Net Income reached approximately 39.8% at ¥91.6B/¥230.0B. Revenue is progressing in line with the plan, but earnings progress is susceptible to interim-period fluctuations in investment gains and losses and insurance finance income and expenses, and may vary depending on market conditions in the second half. Although the earnings forecast was revised during the quarter, there was no revision to the dividend forecast of ¥8.00 per year.
Shareholder Returns
The full-year dividend forecast is ¥8.00 per share, with no revision to the forecast during the period. Dividends of ¥25,609 million are recorded in the quarterly accounts, although this may include a timing mismatch. Based on the full-year Net Income forecast of ¥230.0B, the Payout Ratio is expected to remain at a moderate level when calculated relative to earnings per share. No share repurchases were conducted during the period, with the amount of share buybacks at ¥0.0B; shareholder returns are structured primarily around dividends.
Risk Factors
-
Interest Rate and Market Volatility Risk: Investment gains and losses reversed from ¥-320.2B in the previous year to ¥671.8B in the current period, while insurance finance income and expenses deteriorated to ¥-741.9B from ¥-76.2B in the previous year. This structure, in which the two items fluctuate as opposite sides of the same relationship, may increase earnings volatility depending on market conditions.
-
Thin Capital Buffer: The Equity Ratio declined to 4.0% from 4.4% in the previous year. With Net Assets of ¥8,762.0B against total assets of ¥21.79T, the absolute capital base remains limited. If negative Comprehensive Income of ¥-59.6B continues, the range of capital fluctuations could expand further.
-
Concentration of Segment Earnings: Life Insurance’s profit margin of 0.9% is significantly lower than those of Non-Life Insurance (14.0%) and Banking (18.2%). The profitability of the overall portfolio is therefore structurally susceptible to the sustainability of improved profitability in Life Insurance.
Industry Benchmark (For Reference; Company Analysis)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 5.7% | 5.0% (-0.8%–23.5%) | +0.6pt |
| Net Income Margin | 3.4% | 3.4% (-1.2%–24.6%) | +0.0pt |
Operating margin is slightly above the industry median, while Net Income margin is broadly in line with the median and remains at an average level.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 10.5% | 9.3% (2.0%–17.3%) | +1.2pt |
Revenue growth is slightly above the industry median but has not reached the upper bound of the IQR (17.3%), remaining at a mid-range growth rate within the industry.
※Source: Company analysis
Key Takeaways from the Financial Results
-
The return to profitability from the significant loss recorded in the same period of the previous year, together with the improvement in Operating margin from -13.8% to 5.7% of approximately 1,951bp, was driven by the normalization of Life Insurance segment earnings and the expansion of net interest income resulting from rising interest rates.
-
Comprehensive income was negative at ¥-59.6B compared with Net Income of ¥91.6B, and fluctuations in OCI, primarily related to valuation differences on other securities, affected capital stability. The divergence between improvement in P&L earnings and actual changes in capital is an important point to note.
-
By segment, Life Insurance’s profit margin remained at 0.9%, compared with the high margins of Non-Life Insurance and Banking. The full-year earnings structure is therefore highly dependent on the sustainability of improved profitability in Life Insurance.
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.
---End of Report---